As of 2025-07-15, the Relative Valuation of IGM Biosciences Inc (IGMS) is (72.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.36 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -5414.5%.
The range of the Relative Valuation is (59.15) - (80.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 24.3x | 20.3x |
| Forward P/E multiples | 17.9x - 28.9x | 23.4x |
| Fair Price | (59.15) - (80.25) | (72.28) |
| Upside | -4448.9% - -6000.7% | -5414.5% |
| Date | P/E |
| 2025-07-10 | -0.41 |
| 2025-07-09 | -0.41 |
| 2025-07-08 | -0.40 |
| 2025-07-07 | -0.41 |
| 2025-07-03 | -0.41 |
| 2025-07-02 | -0.40 |
| 2025-07-01 | -0.39 |
| 2025-06-30 | -0.34 |
| 2025-06-27 | -0.33 |
| 2025-06-26 | -0.37 |
| 2025-06-25 | -0.37 |
| 2025-06-24 | -0.36 |
| 2025-06-23 | -0.35 |
| 2025-06-20 | -0.35 |
| 2025-06-18 | -0.35 |
| 2025-06-17 | -0.36 |
| 2025-06-16 | -0.37 |
| 2025-06-13 | -0.37 |
| 2025-06-12 | -0.37 |
| 2025-06-11 | -0.38 |
| 2025-06-10 | -0.41 |
| 2025-06-09 | -0.39 |
| 2025-06-06 | -0.40 |
| 2025-06-05 | -0.37 |
| 2025-06-04 | -0.38 |
| 2025-06-03 | -0.38 |
| 2025-06-02 | -0.38 |
| 2025-05-30 | -0.38 |
| 2025-05-29 | -0.40 |
| 2025-05-28 | -0.37 |
| 2025-05-27 | -0.37 |
| 2025-05-23 | -0.38 |
| 2025-05-22 | -0.36 |
| 2025-05-21 | -0.36 |
| 2025-05-20 | -0.37 |
| 2025-05-19 | -0.37 |
| 2025-05-16 | -0.36 |
| 2025-05-15 | -0.35 |
| 2025-05-14 | -0.34 |
| 2025-05-13 | -0.35 |
| 2025-05-12 | -0.36 |
| 2025-05-09 | -0.34 |
| 2025-05-08 | -0.34 |
| 2025-05-07 | -0.34 |
| 2025-05-06 | -0.35 |
| 2025-05-05 | -0.39 |
| 2025-05-02 | -0.41 |
| 2025-05-01 | -0.41 |
| 2025-04-30 | -0.42 |
| 2025-04-29 | -0.40 |